Ledger.Open graph →
SEC Form D · filed April 12, 2024

Sparrow Pharmaceuticals, Inc

Offering
$15.3M
Sold
$10.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
PORTLAND, OR
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Peter Thompson · Seattle, WADirectorJonathan Root · Maple Grove, MNDirectorKlaus Veitinger · New York, NYDirectorNiall O'Donnell · San Diego, CADirectorRobert Jacks · Portland, ORExec · DirectorPeter Thompson · New York, NYDirectorJonathan Root · San Francisco, CADirectorKlaus Veitinger · Newark, NJDirectorNiall O'Donnell · San Diego, CADirectorRobert Jacks · Newark, NJExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗